Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-11-14 4:42 pm Purchase | 2022-11-03 | 13G | NUVALENT INC NUVL | Flynn James E | 25,466,889 39.240% | 690,611 (+2.79%) | Filing History |
| 2022-10-14 4:51 pm Purchase | 2022-10-10 | 13G | ENHABIT INC EHAB | Flynn James E | 2,846,000 5.740% | 2,846,000 (New Position) | Filing History |
| 2022-10-04 4:32 pm Purchase | 2022-10-03 | 13G | IVERIC BIO INC ISEE | Flynn James E | 6,601,000 5.590% | 1,839,862 (+38.64%) | Filing History |
| 2022-09-30 3:29 pm Purchase | 2022-09-20 | 13G | MERUS N V COM MRUS | Flynn James E | 2,521,553 5.500% | 2,521,553 (New Position) | Filing History |
| 2022-09-23 5:15 pm Purchase | 2022-09-22 | 13G | PHATHOM PHARMACEUTICALS INC CO PHAT | Flynn James E | 2,414,897 5.810% | 2,414,897 (New Position) | Filing History |
| 2022-09-16 5:19 pm Purchase | 2022-09-16 | 13D | LARIMAR THERAPEUTICS INC LRMR | Flynn James E | 16,963,029 42.450% | 11,126,786 (+190.65%) | Filing History |
| 2022-09-12 5:23 pm Sale | 2022-09-08 | 13G | MIRUM PHARMACEUTICALS INC MIRM | Flynn James E | 2,032,335 5.530% | -1,250,577 (-38.09%) | Filing History |
| 2022-08-17 1:11 pm Purchase | 2022-08-17 | 13G | GENEDX HLDGS CORP WGS | Flynn James E | 571,166 4.950% | 147,929 (+34.95%) | Filing History |
| 2022-08-16 5:20 pm Sale | 2022-08-16 | 13G | TERNS PHARMACEUTICALS INC TERN | Flynn James E | 1,860,000 4.940% | -485,959 (-20.71%) | Filing History |
| 2022-08-16 5:19 pm Purchase | 2022-08-16 | 13G | VIGIL NEUROSCIENCE INC VIGL | Flynn James E | 2,054,794 5.780% | 2,054,794 (New Position) | Filing History |
| 2022-08-15 5:47 pm Purchase | 2022-08-11 | 13G | ANAPTYSBIO INC ANAB | Flynn James E | 2,199,900 5.190% | 981,174 (+80.51%) | Filing History |
| 2022-07-05 5:15 pm Purchase | 2022-06-30 | 13D | ACUTUS MED INC AFIB | Flynn James E | 9,644,965 9.400% | 3,780,451 (+64.46%) | Filing History |
| 2022-06-17 08:00 am Purchase | 2022-06-13 | 13G | COGENT BIOSCIENCES INC COGT | Flynn James E | 5,876,805 9.640% | 5,876,805 (New Position) | Filing History |
| 2022-06-06 4:53 pm Purchase | 2022-05-25 | 13G | EVOLUS INC EOLS | Flynn James E | 3,030,299 5.410% | 3,030,299 (New Position) | Filing History |
| 2022-05-19 4:50 pm Purchase | 2022-05-09 | 13G | IMMUNOGEN INC IMGN | Flynn James E | 14,779,590 6.700% | 14,779,590 (New Position) | Filing History |
| 2022-05-17 3:06 pm Sale | 2022-05-17 | 13G | ESPERION THERAPEUTICS INC ESPR | Flynn James E | 5,000,000 4.990% | -5,000,000 (-50.00%) | Filing History |
| 2022-05-11 1:50 pm Purchase | 2022-05-10 | 13G | TARSUS PHARMACEUTICALS INC TARS | Flynn James E | 1,324,214 5.040% | 1,324,214 (New Position) | Filing History |
| 2022-05-10 5:26 pm Purchase | 2022-05-10 | 13G | PEPGEN INC PEPG | Flynn James E | 953,626 4.260% | 953,626 (New Position) | Filing History |
| 2022-05-03 5:11 pm Purchase | 2022-05-03 | 13G | HILLEVAX INC HLVX | Flynn James E | 2,617,948 7.830% | 2,617,948 (New Position) | Filing History |
| 2022-04-27 3:49 pm Purchase | 2022-04-24 | 13D | ACUTUS MED INC AFIB | Flynn James E | 5,864,514 9.400% | 11,590 (+0.20%) | Filing History |